SB2024082338 - Multiple vulnerabilities in IBM Security Guardium



SB2024082338 - Multiple vulnerabilities in IBM Security Guardium

Published: August 23, 2024 Updated: January 31, 2025

Security Bulletin ID SB2024082338
Severity
Medium
Patch available
YES
Number of vulnerabilities 3
Exploitation vector Remote access
Highest impact Data manipulation

Breakdown by Severity

Medium 33% Low 67%
  • Low
  • Medium
  • High
  • Critical

Description

This security bulletin contains information about 3 secuirty vulnerabilities.


1) Improper access control (CVE-ID: CVE-2023-46813)

The vulnerability allows a local user to escalate privileges on the system.

The vulnerability exists due to improper access checking in the #VC handler and instruction emulation of the SEV-ES emulation of MMIO accesses. A local user can gain arbitrary write access to kernel memory and execute arbitrary code with elevated privileges.


2) OS Command Injection (CVE-ID: CVE-2023-51385)

The vulnerability allows a remote attacker to execute arbitrary shell commands on the target system.

The vulnerability exists due to improper input validation when processing user names, if a user name or host name has shell metacharacters, and this name is referenced by an expansion token in certain situations. A remote attacker can execute arbitrary OS commands via an untrusted Git repository.


3) Inadequate encryption strength (CVE-ID: CVE-2023-48795)

The vulnerability allows a remote attacker to perform MitM attack.

The vulnerability exists due to incorrect implementation of the SSH Binary Packet Protocol (BPP), which mishandles the handshake phase and the use of sequence numbers. A remote attacker can perform MitM attack and delete the SSH2_MSG_EXT_INFO message sent before authentication starts, allowing the attacker to disable a subset of the keystroke timing obfuscation features introduced in OpenSSH 9.5.

The vulnerability was dubbed "Terrapin attack" and it affects both client and server implementations.


Remediation

Install update from vendor's website.